BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Hippocampus
,
Human chorionic gonadotropin
,
Vitamin E
,
rs2476601
,
MDM2
,
Lung cancer
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
met protein, human
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
No genes found
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
No biogroups found
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
Lung cancer A549 cells and NCI-H596 cells with MET exon 14 deletion treated with HGF
Hepatocytes from wildtype and Met null mice treated with hepatocyte growth factor
Colon (DiFi) and gastric cancer (GTL-16) cell line gene expression after inhibition of MET or EGFR
Pancreatic carcinoma BxPC-3 cells treated with HGF or MST1
Shiga toxin-induced gene expression in THP-1 monocytic leukemia cells
Explore Curated Studies Results
Literature
Most Relevant Literature
Biomarker MET in tumor pathology].
MET Fusions in NSCLC: Clinicopathologic Features and Response to MET Inhibition.
Optimized Detection of Unknown MET Exon 14 Skipping Mutations in Routine Testing for Patients With N…
The effectiveness of tivantinib for MET-high hepatocellular carcinoma: A protocol for meta analysis.
Exploring circular MET RNA as a potential biomarker in tumors exhibiting high MET activity.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Sym015 (Anti-MET) in Patients With Advanced Solid Tumor Malignancies
Safety, Efficacy and Pharmacokinetic of BPI-9016M in Patients With c-Met- Dysregulated Advanced NSCL…
Capmatinib Plus Trametinib for the Treatment of Metastatic Non-small Cell Lung Cancer With MET Exon …
Marin Protein Hydrolysate and Metabolic Syndrome
A Multicenter, Open Label, Phase I Dose Escalation Study to Evaluate the Safety, Tolerability, and P…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ